drugset / Trial / NCT04402385

Aspirin to Prevent Preeclampsia in Women With Elevated Blood Pressure and Stage 1 Hypertension (ASPPIRE)

NCT04402385

Phase 2 Terminated 50 enrolled Yale University
RandomizedParallel-groupTriple-blindPrevention

Summary

To determine if low dose aspirin reduces the incidence of hypertensive disorders of pregnancy (gestational hypertension, preeclampsia, eclampsia, and HELLP syndrome) in pregnant women with stage 1 hypertension and elevated blood pressure.

Timeline

Start
2020-08-06
Primary completion
2022-06-22
Completion
2022-06-22

Drugs

EvaluationDrugModalityDoseRoute
Subject Aspirin Small molecule 81 mg